Published • loading... • Updated
Artificial Intelligence Boosts Vaccine with First Human Tests and Immune Response
Summary by Portal Mix Vale
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A revolutionary vaccine, developed with the help of artificial intelligence, underwent initial tests in humans, revealing an immune response, Modesta. The phase 1 trial focused on the safety of the immunizer, took place in mid-August 2026 and represents a crucial step in the application of technology to public health. The main proposal for [...]
·Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
